{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:13:27Z","timestamp":1719926007963},"reference-count":38,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T00:00:00Z","timestamp":1331683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aim of the study was to evaluate fat tissue distribution in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients with suppressed viraemia treated with darunavir\/ritonavir (darunavir\/r) monotherapy versus darunavir\/r triple therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was a substudy of the randomized, multicentre, open\u2010label <jats:styled-content style=\"fixed-case\">MONOI\u2010ANRS<\/jats:styled-content> 136 trial. Body fat distribution and metabolic parameters were measured at baseline, week 48 and week 96.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 156 patients of the 225 initially enrolled in the <jats:styled-content style=\"fixed-case\">MONOI<\/jats:styled-content> trial participated in this study, 75 in the darunavir\/r monotherapy arm and 81 in the darunavir\/r triple\u2010therapy arm. The median limb fat increase from baseline was +0.34\u2009kg [interquartile range (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>) \u20130.040 to +1.140\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009&lt;\u20090.001] at week 48 and +0.33\u2009kg (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.14 to +1.26\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009=\u20090.001) at week 96 in the monotherapy arm, while there was no change (\u20130.02\u2009kg; <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.53 to +0.52\u2009kg) at week 48 and then an increase of +0.23\u2009kg (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.45 to +0.87\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009=\u20090.046) at week 96 in the triple\u2010therapy arm. The two arms differed significantly at week 48 (<jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009=\u20090.001) but not at week 96. The median increase in trunk fat was +0.73\u2009kg (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.24 to +1.60\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009&lt;\u20090.001) and 0.60\u2009kg (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.41 to +1.49\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009=\u20090.03) at week 48 and +1.16\u2009kg (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.17 to +2.75\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009&lt;\u20090.001) and +0.90\u2009kg (<jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20130.51 to +2.34\u2009kg; <jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009=\u20090.001) at week 96 in the monotherapy and triple\u2010therapy arms, respectively, with no difference between arms. At week 96, the only biological change was a glucose level elevation in the monotherapy arm (median +4.0\u2009mg\/dL; <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> \u20134.0 to +7.0\u2009mg\/dL) compared with the triple\u2010therapy arm (<jats:italic><jats:styled-content style=\"fixed-case\">P<\/jats:styled-content><\/jats:italic>\u2009=\u20090.012).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Overall, body fat tissue increased in patients on darunavir\/r monotherapy and triple therapy, with no difference between the arms over 96 weeks. The only difference found was a delayed increase in limb fat tissue in the triple\u2010therapy arm compared with the monotherapy arm in the first year.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2012.01004.x","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T03:15:35Z","timestamp":1331781335000},"page":"505-515","source":"Crossref","is-referenced-by-count":12,"title":["Body fat distribution in <scp>HIV<\/scp>\u2010infected patients treated for 96 weeks with darunavir\/ritonavir monotherapy versus darunavir\/ritonavir plus nucleoside reverse transcriptase inhibitors: the <scp>MONOI\u2010ANRS<\/scp>136 Substudy"],"prefix":"10.1111","volume":"13","author":[{"given":"MA","family":"Valantin","sequence":"first","affiliation":[{"name":"INSERM UMR\u2010S 943 and University Pierre and Marie Curie (UPMC)  Paris France"},{"name":"Department of Infectious Diseases Assistance Publique H\u00f4pitaux de Paris (AP\u2010HP) Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kolta","sequence":"additional","affiliation":[{"name":"Rheumatology Department Paris\u2010Descartes University, AP\u2010HP, Cochin Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Flandre","sequence":"additional","affiliation":[{"name":"INSERM UMR\u2010S 943 and University Pierre and Marie Curie (UPMC)  Paris France"},{"name":"Department of Virology, AP\u2010HP Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Algarte Genin","sequence":"additional","affiliation":[{"name":"INSERM UMR\u2010S 943 and University Pierre and Marie Curie (UPMC)  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JL","family":"Meynard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, AP\u2010HP Saint Antoine Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Ponscarme","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, AP\u2010HP Saint Louis Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Slama","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, AP\u2010HP Tenon Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Cuzin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases Purpan Hospital  Toulouse France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"de Kerviler","sequence":"additional","affiliation":[{"name":"Department of Radiology, AP\u2010HP Saint Louis Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Inaoui","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, AP\u2010HP Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Katlama","sequence":"additional","affiliation":[{"name":"INSERM UMR\u2010S 943 and University Pierre and Marie Curie (UPMC)  Paris France"},{"name":"Department of Infectious Diseases Assistance Publique H\u00f4pitaux de Paris (AP\u2010HP) Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp240"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181ca48bf"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200404300-00011"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1086\/380790"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000247574.33998.03"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp071"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00606.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/605440"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181be6be2"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60423-7"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/589622"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000161777.38438.ed"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/135965350901400210","article-title":"Risk factors for loss of virological suppression in patients receiving lopinavir\/ritonavir monotherapy for maintenance of HIV suppression","volume":"14","author":"Pulido F","year":"2009","journal-title":"Antivir Ther"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830285fb"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283348944"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/QAD.0b013e32833dec20","article-title":"Efficacy of darunavir\/ritonavir maintenance monotherapy in patients with HIV\u20101 viral suppression: a randomized open\u2010label, noninferiority trial, MONOI\u2010ANRS 136","volume":"24","author":"Katlama C","year":"2010","journal-title":"AIDS"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832cbcec"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61049-6"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832d7350"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328013d9d7"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2008.0216"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1310\/hct0906-418"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2009.08.001"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/640878"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009520"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01622200"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2009.101"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir324"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0254"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832b4377"},{"key":"e_1_2_6_33_1","first-page":"99","article-title":"Compatibility of different methods for the measurement of visceral fat in different body mass index strata","volume":"16","author":"Berker D","year":"2010","journal-title":"Diagn Interv Radiol"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2013"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328340a28d"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f423dd"},{"key":"e_1_2_6_37_1","unstructured":"Mary\u2010KrauseM Ename\u2010MkoumazokB BentataMet\u2009al.Prevalence of low bone mineral density in HIV\u20101 infected men and women and proposal for a screening strategy.12th European Aids Conference (EACS). Cologne Germany November2009[Abstract n\u00b0 PS5\/3]."},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir188"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/656417"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2012.01004.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2012.01004.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:42:19Z","timestamp":1700584939000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2012.01004.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1468-1293.2012.01004.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2012.01004.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,14]]}}}